ALLIANCEBERNSTEIN L.P. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 89 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$270,000
-16.1%
217,900
+108.1%
0.00%
Q1 2017$322,000
-57.9%
104,700
-44.1%
0.00%
-100.0%
Q4 2016$765,000
-35.7%
187,4000.0%0.00%0.0%
Q3 2016$1,190,000
+17.8%
187,4000.0%0.00%0.0%
Q2 2016$1,010,000
-28.3%
187,400
+11.3%
0.00%0.0%
Q1 2016$1,409,000
+5.9%
168,3000.0%0.00%0.0%
Q4 2015$1,330,000
-8.8%
168,300
-1.8%
0.00%0.0%
Q3 2015$1,458,000
-31.3%
171,300
-0.2%
0.00%
-50.0%
Q2 2015$2,122,000
+10.9%
171,600
+6.5%
0.00%0.0%
Q1 2015$1,914,000
+5.2%
161,1000.0%0.00%0.0%
Q4 2014$1,820,000
+28.7%
161,1000.0%0.00%
+100.0%
Q3 2014$1,414,000
+20.4%
161,1000.0%0.00%0.0%
Q2 2014$1,174,000
+47.7%
161,100
+2.1%
0.00%0.0%
Q1 2014$795,000
+37.8%
157,836
+46.1%
0.00%0.0%
Q4 2013$577,000
-6.2%
108,036
-33.2%
0.00%0.0%
Q3 2013$615,000
-40.9%
161,736
+4.6%
0.00%0.0%
Q2 2013$1,041,000154,6530.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,211,880$17,474,0004.63%
Parametrica Management Ltd 21,228$168,0001.11%
GARRISON BRADFORD & ASSOCIATES INC 82,700$653,0000.73%
Virtus ETF Advisers LLC 33,570$265,0000.73%
Opus Point Partners Management, LLC 122,500$968,0000.64%
NEXTHERA CAPITAL LP 36,000$284,0000.40%
WESTFIELD CAPITAL MANAGEMENT CO LP 7,255,815$57,321,0000.39%
Cannell & Co. 1,051,178$7,751,0000.25%
Tekla Capital Management LLC 853,787$6,745,0000.24%
STONERIDGE INVESTMENT PARTNERS LLC 208,282$1,645,0000.22%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders